4-amino-3-(4-aminophenyl)-furo[3,2-c]pyridine | 799293-74-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃吡啶类
• 英文名称: 4-amino-3-(4-aminophenyl)-furo[3,2-c]pyridine
• 英文别名: 3-(4-aminophenyl)furo[3,2-c]pyridin-4-amine
• CAS: 799293-74-6
• 化学式: C₁₃H₁₁N₃O
• 分子量: 225.25
• InChiKey: CIRCBTIFWOZZKT-UHFFFAOYSA-N

物化性质

• 沸点：
  467.0±45.0 °C(Predicted)
• 密度：
  1.329±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  78.1
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-amino-3-(4-aminophenyl)-furo[3,2-c]pyridine 在 N-溴代丁二酰亚胺(NBS) 、 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 为溶剂， 生成 1-(4-(4-Amino-7-phenylfuro[3,2-c]pyridin-3-yl)phenyl)-3-(2-fluoro-5-(trifluoromethyl)phenyl)urea
  参考文献：
  名称：

  Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases

  摘要：

  A novel class of 3,7-diphenyl-4-amino-thieno and furo[3,2-c]pyridine has been designed based on pharmacophore models of ATP competitive kinase inhibitors. Versatile synthetic methods via double Suzuki coupling to explore SAR have been established and potent inhibitors against angiogenetic targets, VEGFR2, Tie-2, and EphB4, have been successfully discovered. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.050
• 作为产物：
  描述：

  4,5-二氢-4-氧代呋喃[3,2]吡啶 在 ammonium hydroxide 、 四(三苯基膦)钯 、 溴 、 sodium carbonate 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 三氯氧磷 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 四氯化碳 、 乙二醇二甲醚 为溶剂， 生成 4-amino-3-(4-aminophenyl)-furo[3,2-c]pyridine
  参考文献：
  名称：

  Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases

  摘要：

  A novel class of 3,7-diphenyl-4-amino-thieno and furo[3,2-c]pyridine has been designed based on pharmacophore models of ATP competitive kinase inhibitors. Versatile synthetic methods via double Suzuki coupling to explore SAR have been established and potent inhibitors against angiogenetic targets, VEGFR2, Tie-2, and EphB4, have been successfully discovered. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.050

文献信息

• Thienopyridine and furopyridine kinase inhibitors
  申请人：Betschmann Patrick

  公开号：US20050026944A1

  公开（公告）日：2005-02-03

  Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有以下化学式的化合物对抑制蛋白酪氨酸激酶具有用处。本发明还公开了制备这些化合物的方法、含有这些化合物的组合物，以及使用这些化合物进行治疗的方法。
• Novel chemical compounds
  申请人：Miyazaki Yasushi

  公开号：US20080182868A1

  公开（公告）日：2008-07-31

  This invention relates to newly identified compounds for treating and preventing tumors and cancers, and methods for treating proliferative diseases associated with the imbalance or inappropriate activity of tyrosine kinases implicated in proliferative diseases.

  本发明涉及治疗和预防肿瘤和癌症的新型化合物，以及用于治疗与参与增殖性疾病的酪氨酸激酶失衡或不适当活性相关的增殖性疾病的方法。
• THIENOPYRIDINE AND FUROPYRIDINE KINASE INHIBITORS
  申请人：Betschmann Patrick

  公开号：US20070155776A1

  公开（公告）日：2007-07-05

  Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有化学式的化合物对于抑制蛋白质酪氨酸激酶具有用处。本发明还公开了制备该化合物的方法、含有该化合物的组合物以及使用该化合物的治疗方法。
• Substituted thieno and furo-pyridines
  申请人：SmithKline Beecham Corporation

  公开号：US07592352B2

  公开（公告）日：2009-09-22

  This invention relates to newly identified compounds for treating and preventing tumors and cancers, and methods for treating proliferative diseases associated with the imbalance or inappropriate activity of tyrosine kinases implicated in proliferative diseases.

  本发明涉及一种新识别的化合物，用于治疗和预防肿瘤和癌症，并用于治疗与酪氨酸激酶失衡或不适当活性有关的增殖性疾病的方法。
• [EN] NOVEL CHEMICAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004100947A3

  公开（公告）日：2005-03-24